Complex coronary cases
PCI of RCA CTO via Retrograde Recanalization Technique – Sept 2016

45 year old male presented with new onset CCS Class IV angina and lateral ST-T changes. A Cardiac Cath on June 27, 2016 revealed 3V CAD: totally occluded proximal RCA, 90% mid LAD, 70% LCx-OM2 with normal systolic LV function; SYNTAX Score of 17. Patient underwent successful intervention of culprit mid LAD using Promus Premier DES. Patient continued on aggressive CAD risk factor modification and maximal medical therapy. Patient still has Class II angina and a stress MPI revealed moderate inferoposterior ischemia. Patient is now planned for PCI of RCA CTO via retrograde recanalization technique.

Moderator: Sameer Mehta, MD

1:48:43

Q&A
Q
Congratulations about the Top NYS Ranking. Do you think it is because of the hospital or because of the systems that you have created? Or both?
A.

To continue to remain on top for last 18 years is the main result of hard work, technical expertise and developing & implementing the guideline tested specific protocols in the cath lab. This is even more important when 25% of PCIs at Sinai are done by the voluntary interventionalists whose annual volume is between 30-50 PCIs per year. Mount Sinai Hospital has provided a great infrastructure support which has enabled us to place check and balances at various levels where NPs and interventional fellows play a major role in overall care of PCI pts.


Q
Is there also a ranking of Structural Heart Interventions?
A.

Presently their is no ranking of Structural heart interventions at present from the NY State; they only report the annual institutional volume of TAVR cases. We are second to Columbia in the NY State in the TAVR volume while we lead the NY State in the PCI volume.


Q
What do you personally think is more significant - top in volume or top in safety?
A.

Of course safety is the most important parameter of PCI performance but as you well know both safety and volume go hand & hand as higher volume drives better safety and quality as long as the infrastructure can support the operations.


Q
Of this massive PCI volume, what proportion do you feel are complex interventions?
A.

About 40-45% of our PCI cases are complex as defined by CTO, severe calcification, bifurcation and LM lesions.


Q
What proportion of your cases are International cases?
A.

International cases are still a small number around 3-4% only.


Q
How is the PCI volume at your sister facilities in NYC?
A.

All hospital including us have faced the decline in the PCI volume in last 4-5 years but many other sister hospitals have major decline. Our PCI volume has declined aggregate 10% in last 5 years while this number is close to 20% at many other NY hospitals.


Q
And their safety profile?
A.

We do lead in safety with reported 30 day risk adjusted mortality lower in most of the PCI categories. This has been consistent over last 18yrs since PCI outcomes are reported by the NY State. Yes few other NY hospitals do get safety ratings from time to time but not consistently.


Q
Do these Mount Sinai Hospital affiliates refer complex interventions to you?
A.

Yes we get some complex cases from our Sinai affiliates but majority comes from outside hospitals; largely from NJ.


Q
On an average, how many PCI procedures does an Interventional Fellow scrub in?
A.

We now do approx 4000 PCIs per year with 8 Interventional fellows, who individually do approx 500 cases each. Each interventional fellow also does approx 90 PTAs and approx 50 Structural heart interventional cases (BAV and TAVR).


Q
Do you feel that even more operators can achieve the very coveted Double Star recognition? Are you constantly guiding them?
A.

Yes I believe that many other interventionalists also can get the double star safety record but need to develop superior technical skills, take complex cases, pay attention to minute details and develop an effective infrastructure of pre and post PCI care to detect any trouble at the earliest such DAPT compliance and Eatly recognition of vascular and ischemic complications and their quick management.


comments

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Mount Sinai Hospital, One Gustave L. Levy Place, Box, New York, NY, 10029, https://ccclivecases.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

suggestion
Suggestions
Staged PCI of RCA multilayer DES CTO ISR using rotational atherectomy and IVBT – November 2020
Views 288

Case and Plan: 65-year old male with known long standing history of chronic ischemic heart disease requiring multiple PCI’s over the years after declining CABG, presented with CCS Class III angina and high risk stress MPI for multivessel ischemia. A Cardiac Cath on September 28, 2020 revealed 3 V CAD: 100% proximal RCA due to […]


Complex Multivessel PCI in a High SYNTAX Score Patient – October 2020
Tags: | |
Views 352

Case and Plan: 74-year-old obese male on HD presented with CCS Class II angina and positive SPECT MPI on July 14, 2020 done as pre-op for renal transplant revealing moderate apical, inferior and inferolateral ischemia. A Cardiac Cath on August 20, 2020 revealed 3 V CAD: 70% mid RCA, 100% RCA-AV Cont, subtotal calcified mid-distal […]


Radial PCI of Long Complex Calcified LAD post TAVR – September 2020
Views 278

Case and Plan: 78 year-old-male presented on August 7, 2020 with progressive exertional dyspnea, NYHA class III. Workup revealed severe AS (AVA 0.7cm2), normal LV function and STS mortality of 1.1%. After heart team discussion, patient underwent successful TAVR using 26mm SAPIEN-3 Ultra with excellent results, AV area of 2.0cm2 and no PVL. A coronary […]


Stent Ablation with RA of Underexpanded Multilayer DES – August 2020
Tags: | |
Views 446

63 year-old male with known CAD, CABG x2 (1999) and multiple PCI’s to SVG to RCA and LCx branches presented with CCS Class IV angina and non-STEMI (TnI 1.2U). A Cardiac Cath on June 22, 2020 revealed patent LIMA to LAD, non obstructive LCx branches with patent prior stents and 90% multilayer in-stent restenosis of […]